Source link : https://www.newshealth.biz/health-news/are-changes-imminent-timeline-unclear/
After years of debate and disagreement, could an improved, more user-friendly version of iPLEDGE be on the horizon? iPLEDGE, the US Food and Drug Administration (FDA)-required Risk Evaluation and Mitigation Strategy (REMS) program launched in 2010, aims to manage the risks for the teratogenic acne drug isotretinoin and prevent fetal exposure. But it’s been dogged […]
Author : News Health
Publish date : 2024-08-26 11:36:01
Copyright for syndicated content belongs to the linked Source.
Categories